Cargando…

Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein

Detalles Bibliográficos
Autores principales:	Kim, Ji Yeun, Kim, Young Il, Park, So Jung, Kim, In Ki, Choi, Young Ki, Kim, Sung-Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2018
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125825/ https://www.ncbi.nlm.nih.gov/pubmed/29772395 http://dx.doi.org/10.1016/j.ijantimicag.2018.05.003

Ejemplares similares

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017)

Evaluating MERS-CoV Entry Pathways
por: Qing, Enya, et al.
Publicado: (2019)

MERS-CoV
por: Müller, Marcel A
Publicado: (2014)

Variations in Spike Glycoprotein Gene of MERS-CoV, South Korea, 2015
por: Kim, Dae-Won, et al.
Publicado: (2016)

Immunization of MERS-CoV-2-infected mice with a sublethal dose of MERS-CoV or VRP-MERS-S
por: Zheng, Jian, et al.
Publicado: (2023)

Atypical presentations of MERS-CoV infection in immunocompromised hosts
por: Kim, Si-Ho, et al.
Publicado: (2017)

The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014)

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)

MERS-CoV spike protein: Targets for vaccines and therapeutics
por: Wang, Qihui, et al.
Publicado: (2016)

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2013)

MERS-CoV Infection in a Pregnant Woman in Korea
por: Jeong, Soo Young, et al.
Publicado: (2017)

A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
por: Park, Jung-Eun, et al.
Publicado: (2022)

Persistent Environmental Contamination and Prolonged Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea
por: Jeong, Hye Won, et al.
Publicado: (2015)

Human endogenous retrovirus-enveloped baculoviral DNA vaccines against MERS-CoV and SARS-CoV2
por: Cho, Hansam, et al.
Publicado: (2021)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
por: Lyoo, Kwang-Soo, et al.
Publicado: (2023)

Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
por: Kim, Sang Il, et al.
Publicado: (2019)

Inclusion of MERS‐spike protein ELISA in algorithm to determine serologic evidence of MERS‐CoV infection
por: Trivedi, Suvang, et al.
Publicado: (2017)

Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein
por: Xia, Shuai, et al.
Publicado: (2014)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

MERS-CoV diagnosis: An update
por: Al Johani, Sameera, et al.
Publicado: (2016)

Mers-CoV and Zika Virus
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

MERS-CoV: in search of answers
por: Petherick, Anna
Publicado: (2013)

Molecular aspects of MERS-CoV
por: Rabaan, Ali A., et al.
Publicado: (2017)

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors
por: Park, Young-Jun, et al.
Publicado: (2019)

Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV
por: V. K., Priya, et al.
Publicado: (2021)

Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity
por: Kim, C.-J., et al.
Publicado: (2016)

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS – MERS, MERS CoV
Publicado: (2017)

MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein
por: Park, Byoung Kwon, et al.
Publicado: (2021)

The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV
por: Awasthi, Mayanka, et al.
Publicado: (2020)

NeoCoV Is Closer to MERS-CoV than SARS-CoV
por: Hassan, Mohamed M, et al.
Publicado: (2020)

Post-traumatic stress symptoms in hemodialysis patients with MERS-CoV exposure
por: Cho, A Jin, et al.
Publicado: (2020)

Inability of rat DPP4 to allow MERS-CoV infection revealed by using a VSV pseudotype bearing truncated MERS-CoV spike protein
por: Fukuma, Aiko, et al.
Publicado: (2015)

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
por: D’Arco, Annalisa, et al.
Publicado: (2023)

Growth and Quantification of MERS‐CoV Infection
por: Coleman, Christopher M., et al.
Publicado: (2015)

Pilgrims and MERS-CoV: what’s the risk?
por: Soliman, Tarek, et al.
Publicado: (2015)

MERS-CoV: the intermediate host identified?
por: de Wit, Emmie, et al.
Publicado: (2013)

Drivers of MERS-CoV Emergence in Qatar
por: Farag, Elmoubasher, et al.
Publicado: (2018)

Tracking the transmission and evolution of MERS-CoV
por: Hui, David S
Publicado: (2013)

Assessing the pandemic potential of MERS-CoV
por: Bauch, Chris T, et al.
Publicado: (2013)

MERS-CoV: Ein aktueller Überblick
por: Bundschuh, Matthias, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7370sdkj84hlckj6dqddspijap